31378968|t|Assessment of Transporter Polymorphisms as a Factor in a BCRP Drug Interaction Study With Lanabecestat.
31378968|a|Lanabecestat is a human beta-site amyloid precursor protein-cleaving enzyme 1 inhibitor in development to slow disease progression in patients with early Alzheimer's disease. The study evaluated the breast cancer resistance protein (BCRP) inhibition potential of lanabecestat on the pharmacokinetics (PK) of rosuvastatin, a probe for BCRP activity, in healthy white subjects who were not carriers of SLCO1B1 (c.521T>C), not homozygotes for ABCG2 (c.421C>A or c.34G>A), and not heterozygotes of ABCG2 (c.421C>A and c.34G>A). The safety of lanabecestat + rosuvastatin, the effects of rosuvastatin on the PK of lanabecestat, and the effects of multiple genetic polymorphisms on rosuvastatin exposure were assessed. Geometric mean ratios of the maximum observed rosuvastatin concentration (Cmax ), area under the rosuvastatin concentration-versus-time curve (AUC) from time 0 to infinity, and time of maximum observed drug concentration (tmax ) when rosuvastatin was administered alone and with lanabecestat were contained within 0.8-1.25, as were lanabecestat AUC at steady state and tmax at steady state when lanabecestat was administered alone or with rosuvastatin. Lanabecestat Cmax at steady state increased 8% in the presence of rosuvastatin. Except for an approximately 80% increase of rosuvastatin AUC (P < .05) in the heterozygotes of ABCG2 c.421C>A relative to the CC genotype, there were no statistically significant associations between rosuvastatin exposure and polymorphisms assessed. Lanabecestat + rosuvastatin was associated with few treatment-emergent adverse events, all of which resolved and were mild. Lanabecestat does not meaningfully impact BCRP activity; therefore, restriction of concomitant administration with BCRP substrates, such as rosuvastatin, may be unnecessary.
31378968	57	61	BCRP	Gene	9429
31378968	90	102	Lanabecestat	Chemical	MESH:C000608388
31378968	104	116	Lanabecestat	Chemical	MESH:C000608388
31378968	122	127	human	Species	9606
31378968	128	181	beta-site amyloid precursor protein-cleaving enzyme 1	Gene	23621
31378968	238	246	patients	Species	9606
31378968	258	277	Alzheimer's disease	Disease	MESH:D000544
31378968	303	316	breast cancer	Disease	MESH:D001943
31378968	337	341	BCRP	Gene	9429
31378968	367	379	lanabecestat	Chemical	MESH:C000608388
31378968	412	424	rosuvastatin	Chemical	MESH:D000068718
31378968	438	442	BCRP	Gene	9429
31378968	504	511	SLCO1B1	Gene	10599
31378968	513	521	c.521T>C	DNAMutation	tmVar:c|SUB|T|521|C;HGVS:c.521T>C;VariantGroup:1;CorrespondingGene:10599;RS#:4149056;CorrespondingSpecies:9606;CA#:6476722
31378968	544	549	ABCG2	Gene	9429
31378968	551	559	c.421C>A	DNAMutation	tmVar:c|SUB|C|421|A;HGVS:c.421C>A;VariantGroup:0;CorrespondingGene:9429;RS#:2231142;CorrespondingSpecies:9606;CA#:129179
31378968	563	570	c.34G>A	DNAMutation	tmVar:c|SUB|G|34|A;HGVS:c.34G>A;VariantGroup:2;CorrespondingGene:9429;RS#:2231137;CorrespondingSpecies:9606;CA#:129174
31378968	598	603	ABCG2	Gene	9429
31378968	605	613	c.421C>A	DNAMutation	tmVar:c|SUB|C|421|A;HGVS:c.421C>A;VariantGroup:0;CorrespondingGene:9429;RS#:2231142;CorrespondingSpecies:9606;CA#:129179
31378968	618	625	c.34G>A	DNAMutation	tmVar:c|SUB|G|34|A;HGVS:c.34G>A;VariantGroup:2;CorrespondingGene:9429;RS#:2231137;CorrespondingSpecies:9606;CA#:129174
31378968	642	654	lanabecestat	Chemical	MESH:C000608388
31378968	657	669	rosuvastatin	Chemical	MESH:D000068718
31378968	686	698	rosuvastatin	Chemical	MESH:D000068718
31378968	712	724	lanabecestat	Chemical	MESH:C000608388
31378968	779	791	rosuvastatin	Chemical	MESH:D000068718
31378968	862	874	rosuvastatin	Chemical	MESH:D000068718
31378968	913	925	rosuvastatin	Chemical	MESH:D000068718
31378968	1050	1062	rosuvastatin	Chemical	MESH:D000068718
31378968	1095	1107	lanabecestat	Chemical	MESH:C000608388
31378968	1148	1160	lanabecestat	Chemical	MESH:C000608388
31378968	1211	1223	lanabecestat	Chemical	MESH:C000608388
31378968	1255	1267	rosuvastatin	Chemical	MESH:D000068718
31378968	1269	1281	Lanabecestat	Chemical	MESH:C000608388
31378968	1335	1347	rosuvastatin	Chemical	MESH:D000068718
31378968	1393	1405	rosuvastatin	Chemical	MESH:D000068718
31378968	1444	1449	ABCG2	Gene	9429
31378968	1450	1458	c.421C>A	DNAMutation	tmVar:c|SUB|C|421|A;HGVS:c.421C>A;VariantGroup:0;CorrespondingGene:9429;RS#:2231142;CorrespondingSpecies:9606;CA#:129179
31378968	1549	1561	rosuvastatin	Chemical	MESH:D000068718
31378968	1599	1611	Lanabecestat	Chemical	MESH:C000608388
31378968	1614	1626	rosuvastatin	Chemical	MESH:D000068718
31378968	1723	1735	Lanabecestat	Chemical	MESH:C000608388
31378968	1765	1769	BCRP	Gene	9429
31378968	1838	1842	BCRP	Gene	9429
31378968	1863	1875	rosuvastatin	Chemical	MESH:D000068718
31378968	Negative_Correlation	MESH:C000608388	MESH:D001943
31378968	Negative_Correlation	MESH:C000608388	23621
31378968	Cotreatment	MESH:C000608388	MESH:D000068718
31378968	Negative_Correlation	MESH:C000608388	9429
31378968	Association	MESH:D001943	9429
31378968	Negative_Correlation	MESH:C000608388	MESH:D000544
31378968	Association	MESH:D000068718	9429

